pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 10·1 min read
save

ADA CEO apologizes for expelling five members over protest literature, vows review and trust rebuilding

Jun 10, 2026·read at STAT ↗Negative

Five members of the American Diabetes Association were removed from its annual scientific sessions in New Orleans after distributing editorial material that criticized federal research funding cuts. The incident sparked concern among the diabetes community.

Charles Henderson, the ADA chief executive officer, issued a three minute video apology, naming Dr. Stephen Kahn, Dr. Desmond Schatz, Dr. Aaron Kelly, Dr. Maureen Gannon and Dr. Justin Ryder. He expressed regret for the hurt, frustration and pain the expulsion caused.

The association announced it will launch a review of the events to understand what went wrong and to rebuild trust with members and stakeholders.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Diabetes association leader apologizes for expulsion of members, pledges to rebuild trust”

read at STAT ↗
748 words · retrieved Jun 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2National Institutes of Health
drugs
Obesity
topics
Type 2 Diabetes10Cardiology4Endocrinology & Metabolism2Pain2Obesity

related stories

  • Aug 11Stopping statins in people over 75 at low risk for heart disease didn’t increase deathsSTAT
  • Jul 18Opinion: STAT readers on the value of primary care, obesity as a disease, and moreSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 9Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cutsSTAT
  • 1d ago‘Tactical athletes’ get new guidance for cardiovascular fitnessSTAT